High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial
Author(s) -
Yvonne W. Wu,
Amit Mathur,
Taeun Chang,
Robert C. McKinstry,
Sarah B. Mulkey,
Dennis E. Mayock,
Krisa P. Van Meurs,
Elizabeth E. Rogers,
Fernando F. Gonzalez,
Bryan A. Comstock,
Sandra E. Juul,
Michael E. Msall,
Sonia L. Bonifacio,
Hannah C. Glass,
An N. Massaro,
Lawrence Dong,
Katherine W. Tan,
Patrick J. Heagerty,
Roberta A. Ballard
Publication year - 2016
Publication title -
pediatrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.611
H-Index - 345
eISSN - 1098-4275
pISSN - 0031-4005
DOI - 10.1542/peds.2016-0191
Subject(s) - medicine , hypothermia , erythropoietin , encephalopathy , hypoxic ischemic encephalopathy , hypoxia (environmental) , anesthesia , oxygen , chemistry , organic chemistry
To determine if multiple doses of erythropoietin (Epo) administered with hypothermia improve neuroradiographic and short-term outcomes of newborns with hypoxic-ischemic encephalopathy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom